<DOC>
	<DOCNO>NCT01429545</DOCNO>
	<brief_summary>The purpose study compare tocolytic efficacy , effectiveness safety Atosiban comparison combination Atosiban Nifedipine together .</brief_summary>
	<brief_title>Single Versus Combination Therapy Acute Tocolysis</brief_title>
	<detailed_description>Preterm birth , define birth le 37+0 week gestation , important determinant adverse infant outcome . It account 5 11 % births world , represent single large cause mortality morbidity newborns major cause morbidity pregnant woman . These baby increase risk cerebral palsy , chronic pulmonary insufficiency handicap result suboptimal performance school decrease abstractive thinking compare infant born term . The economic burden society cater preterm baby high . A multi-level modeling hospital service utilization cost profile preterm birth do 2005 United Kingdom , outline huge economic consequence preterm birth first 10 year life . Furthermore , recent data Denmark show overall increase proportion preterm delivery 22 % 1995 2004 ( 5.2 % 6.3 % ) . Neonatal mortality decline , mostly due improve management low birth weight baby rather prevention preterm labor ( PTL ) . The common treatment use management PTL involve pharmacological inhibition preterm uterine contraction . Perinatal death morbidity result PTL strongly relate early gestational age also antenatal administration steroid transfer tertiary care centre utero birth.6 Hence , choice tocolytic agent depend ability delay delivery least 48 hour time administration steroid preferably longer without maternal fetal side effect . There considerable variation type tocolytic agent use different part world . Single agent tocolysis use ritodrine ( β-agonist ) , atosiban ( oxytocin antagonist ) nifedipine ( calcium channel blocker ) common practice . Atosiban show comparable effectiveness β-agonists improve side-effect profile similar see placebo study . Meta analysis Cochrane systematic review fail demonstrate superiority atosiban betamimetics placebo term tocolytic efficacy infant outcome , , maternal drug reaction require treatment cessation few atosiban . Nifedipine agent associate improved perinatal outcome fewer maternal side-effects betamimetics . A direct comparison atosiban nifedipine show drug equally effective acute tocolysis , however maternal side-effects pronounced nifedipine . Due difference pharmacokinetics pharmacodynamics , one may expect improve tocolysis two agent combine . In vitro study demonstrate simultaneous blockade different pathway could result additive even synergistic effect capable produce good uterine relaxation induce drug alone . Accordingly , use multiple agent therapy suggest way forward tocolytic search . In observational study , combination therapy without serious side effect use management PTL extremely early gestation Ingemarsson et al.3 However , test structured human trial . The objective study compare tocolytic efficacy safety combination atosiban nifedipine single agent , atosiban treatment PTL .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Atosiban</mesh_term>
	<mesh_term>Vasotocin</mesh_term>
	<criteria>Clinical diagnosis preterm labour Women singleton pregnancy Women preterm prelabour rupture membrane Women indication emergency delivery prolongation pregnancy contraindicate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Tocolysis</keyword>
	<keyword>atosiban</keyword>
	<keyword>nifedipine</keyword>
	<keyword>combination</keyword>
</DOC>